1. China Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Cofoe Medical Technology Co., Ltd. Class A

Cofoe Medical Technology Co., Ltd. Class A

27.66
HKD
-0.04
(-0.14%)
6.96BMarket Cap
Oct 29Next Earn
Cofoe Medical Technology Co., Ltd. Class A
HKEX:1187
(Hong Kong Exchange)

Recent

price

27.66

P/E

ratio

- -

div

yld

5.07%

ROIC.AI

2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
CNY
5.45
6.79
9.37
15.21
13.8
14.31
13.92
14.64
16.68
- -
Revenue per Share
-0.15
0.41
0.79
2.72
2.6
1.45
1.24
1.53
1.83
- -
Basic EPS, GAAP
-0.36
-0.15
-0.31
0.78
-1.66
-2.6
0.1
2.66
2.55
- -
Free Cash Flow per Basic Share
0.02
0.02
0.04
0.21
0.02
1.25
1.22
1.84
1.83
1.21
Dividend per Share
1.07
1.49
3.82
6.36
23.78
24.08
23.41
22.94
23.3
23.43
Book Value per Share
1.05
1.46
3.39
4.98
22.58
21.78
21.11
20.02
20.12
20.62
Tangible Book Value per Share
156
160
156
156
165
208
205
204
203
210
Basic Weighted Avg Shares
851
1,087
1,462
2,375
2,276
2,977
2,854
2,983
3,387
- -
Sales/Revenue/Turnover
-1.32
8.3
10.83
22.12
23.14
11.04
9.74
12.12
11.68
- -
Operating Margin (%)
1
4
7
16
65
100
136
162
184
- -
Depreciation Expense
-24
66
124
424
429
302
254
312
372
- -
Net Income, GAAP
- -
14.99
14.91
15.09
15.49
9.68
11.49
16.04
13.04
- -
Effective Tax Rate (%)
-2.8
6.09
8.46
17.85
18.85
10.13
8.91
10.45
10.97
- -
Profit Margin (%)
109
166
477
496
3,836
3,013
2,744
2,564
2,247
2,875
Working Capital
- -
- -
- -
53
93
115
171
187
68
61
LT Debt
167
235
599
995
4,965
5,033
4,908
4,802
4,903
5,563
Total Equity
- -
26.94
28.9
44.34
13.2
6.2
4.72
5.59
6.55
- -
Return on Invested Capital (%)
- -
33.66
30.98
42.56
13.24
5.82
4.85
5.8
6.77
- -
Return on Capital (%)
- -
33.17
29.83
53.39
14.44
6.05
5.13
6.43
7.69
- -
Return on Common Equity (%)

Capital Structure

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
758
955
807
LT Borrowings
- -
- -
- -
LT Finance Leases
68
66
61
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
209
209
236
Market Capitalization
- -
- -
6,021

Working Capital

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
3,835
4,164
4,638
Cash, Cash Equivalents & STI
2,439
2,671
3,062
Accounts Receivable, Net
405
429
389
Inventories
675
677
788
Total Current Liabilities
1,589
2,010
1,763
Payables & Accruals
- -
- -
- -
ST Debt
758
955
807
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
79.55%
2.09%
Free Cash Flow
- -
440.3%
-4.65%
Net Income, GAAP
- -
-0.48%
19.2%
Sales/Revenue/Turnover
- -
8.12%
13.56%
Total Cash Common Dividend
- -
1,893.42%
-0.72%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
807
751
690
734
2,983
2025
738
758
- -
990
3,387
2026
1,012
1,059
- -
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.5
0.41
0.33
0.29
1.53
2025
0.45
0.36
- -
0.53
1.83
2026
0.52
0.43
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
1.21
0.02
0.61
1.84
2025
0.01
1.17
- -
0.02
1.83
2026
0.01
1.12
- -
- -
- -
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Cofoe Medical Technology Co., Ltd. engages in the research, development, production, sales, and service of home care medical devices in China. The company provides a broad portfolio of medical and wellness products designed for disease treatment, rehabilitation, daily health maintenance, and life quality enhancement; including rehabilitation aids such as hearing aids, electric wheelchairs, and orthopedic/posture correction devices; medical care products including dressing and ostomy care; health monitoring devices such as metabolic disease testing products and thermometers; respiratory support equipment including non-invasive ventilators and nebulizers; traditional Chinese medicine therapy devices and other physiotherapy equipment. It operates across multiple product categories, brands, and service types intended for consumer and professional use, with emphasis on home-use medical devices and related accessories. The company manufactures, markets, and services these products through a network of subsidiaries and branch companies, targeting consumers, pharmacies, distributors, and e-commerce platforms. Cofoe maintains a significant emphasis on R&D and product innovation, seeking to expand online and offline sales channels while enhancing digitalized operations and brand influence. Headquarters are in China, and the company maintains a broad geographic footprint within the country to support nationwide distribution, with ongoing expansion into overseas markets and collaboration with partners to advance AI-enabled, digitalized home care medical solutions. Founded in 2000, the company states a substantial footprint through numerous subsidiaries and holding structures, underscoring its role as a leading professional household medical devices manufacturer in its region. Cofoe is positioned to provide integrated solutions across its core product categories, including blood pressure monitors, thermometers, nebulizers, oxygen concentrators, hearing aids, glucose meters, ostomy supplies, wheelchairs, hospital beds, and related DME, supported by ongoing product development, regulatory compliance, and quality assurance programs to meet market and customer requirements. The company reports active engagement in strategic alliances, funding events, and capacity upgrades as part of its latest corporate developments to strengthen market presence and accelerate growth.